Human immunodeficiency virus (HIV), the causative agent of AIDS, can devastate the immune system. Although the pathogenesis of AIDS is clearly related to the tropism of the virus for CD4+ T lymphocytes (13, 22, 26, 37, 38, 46) , a wide variety of cell types, all bearing CD4, can be infected by HIV type 1 (HIV-1) (reviewed in reference 43). However, there is mounting evidence that CD4-cells are also susceptible to HIV-1 infection in vivo and in vitro (7) , raising the possibility that HIV can enter cells via a receptor other than the CD4 glycoprotein. Recent studies have shown that HIV-1 infection of some CD4+ cells can occur via a CD4-independent mechanism (11, 24, 51) . Taken together, these studies extended the original host range of HIV-1 and raised the possibility that multiple receptors for HIV-1 exist.
The nature and role of humoral and cellular immune mechanisms against HIV have not been fully characterized. Natural killer (NK) cells represent a discrete leukocyte subset distinct from T and B lymphocytes (reviewed in reference 48). NK cells have been identified in peripheral blood as a population of T-cell-receptor-negative cells that express CD16 (Fc-yRIII, a low-affinity receptor for the Fc fragment of immunoglobulin G [IgG] ) and CD56 (NKH1) cell surface markers. NK cells mediate two forms of cytotoxicity: (i) lysis of tumor cells and virus-infected cells in a non-MHC-restricted manner and without prior sensitization; (ii) through CD16, NK cells can lyse IgG antibody-coated target cells; this mechanism is known as antibody-dependent cellular cytotoxicity. NK cells may provide the first line of defense against certain viruses before activation of specific humoral and cellular immune mechanisms. Decreased NK cell activity has been reported in patients with a variety of different diseases (48) . Several studies have shown a corre-* Corresponding author. lation between low levels of NK cell activity and the severity of viral infections in immunocompromised hosts. For example, in immunosuppressed recipients of a bone marrow transplant, a correlation exists between fatal cytomegalovirus (CMV) infection and failure to develop NK cell and cytotoxic T-lymphocyte-mediated cytotoxicity (40) . NK cell-mediated antibody-dependent cellular cytotoxicity may play an important role in the pathogenesis of HIV-1 infection (49); however, conflicting data have appeared concerning NK cell activity in AIDS patients (reviewed in reference 5), although in most studies decreased NK cell-mediated cytotoxicity was observed. Reported differences among studies may be attributed to different patient populations, different target cells, or different assay conditions. Nevertheless, impaired NK cell activity is one of the many immunological defects observed in patients with AIDS and related syndromes, and its cause remains unclear.
We show for the first time in this report that purified NK cells, which neither bear the CD4 antigen on their surface nor contain CD4 mRNA, can be productively infected in vitro by various HIV-1 isolates.
MATERIALS AND METHODS
NK cells. All experiments were performed on clonal and polyclonal populations of human peripheral blood NK cells. Polyclonal peripheral blood NK cells were prepared by a method similar to that previously described by Perussia et al. (32) . Briefly, peripheral blood mononuclear cells (PBMC) from healthy adult donors who were seronegative for hepatitis B virus and HIV were isolated by centrifugation over Ficoll CPE, the monolayers were trypsinized, and the cells were washed and frozen at -190°C until use. K562 cells passaged in RPMI 1640 medium supplemented with 5% heat-inactivated FBS, 2% vitamins, and 2 mM glutamine were cryopreserved as described above. IIIB-HUT78, maintained in RPMI 1640 containing 10% FBS, was used as previously described (2) . Cryopreserved targets were thawed rapidly, washed twice, and resuspended in 0.2 ml of Hanks balanced salt solution. Na251CrO4 (50 mCi of 407 mCi/mg; ICN Radiochemicals, Irvine, Calif.) was added to 1 x 106 to 2 x 106 cells. After 1 h of incubation at 37°C in 5% CO2 with gentle shaking every 15 min, the cells were washed three times and then resuspended in RPMI 1640 with 10% FBS at a concentration of 5 x 104 cells per ml. In preliminary experiments, effector-to-target cell (E:T) ratios of 50:1 to 1:1 were tested, and curves were obtained for percent specific lysis versus E:T ratios. E:T ratios of 6:1 for K562 cells and 25:1 for CMV-FS4 and IIIB-HUT78 targets gave levels of cytotoxicity on the linear portion of respective curves and were used in subsequent experiments. A total of 5 x 103 target cells and 3 x 104 or 1.25 x 105 effector cells were added to round-bottom microtiter wells (Linbro Chemical Co., Hamden, Conn.). All determinations were done in triplicate. Plates were centrifuged at 100 x g for 5 min and then incubated for 4 h (K562) or 18 h (CMV-FS4 and IIIB-HUT78) at 37°C in 5% CO2. After incubation, 0.1 ml of supernatant was collected and its radioactivity was counted in a gamma counter 4000 (Beckman Instruments, Inc., Fullerton, Calif.). Percent 51Cr release was calculated by using the following formula: percent 51Cr release = 100 x [(cpm experimental -cpm spontaneous)]/[(cpm total -cpm spontaneous)], where spontaneous release was that obtained from target cells incubated with medium alone, total release was that obtained from target cells incubated with 1% Triton X-100, and cpm is counts per minute.
RESULTS
Characterization of NK cells: phenotype and CD4 mRNA analysis. HIV-seropositive human serum. A total of 10 to 20% of infected cells expressed HIV p24 antigen, whereas with the seropositive serum viral antigens were detected in 20% of cells (Fig. 6) . As a positive control, 70 to 80% of IIIB-HUT78 cells expressed HIV antigen, in agreement with our previous results (2) . Irrelevant isotype-matched MAb and a seronegative human serum did not react with HIV-infected NK cells.
Effect of anti-CD4 and anti-CD16 MAbs on infection of NK cells. To determine the ability of anti-CD4 MAb (Leu-3a) or anti-CD16 MAb (3G8) to inhibit HIV infection, we performed blocking experiments. When NK cells were incubated with Leu-3a or isotype-matched control MAb and then infected with strain IIIB or SF162, no inhibition of virus was observed as determined by p24 antigen production (Table 3) . When MAb 3G8 was used, incomplete blocking was detected at day 4 postinfection, while at day 8 no blocking was seen (0 to 5%). When PHA-IL-2-stimulated PBMC were incubated with Leu-3a, 75 to 90% inhibition of infection was detected, while little or no inhibition was observed when 3G8 was used (Table 3) . Syncytium assays. We next assessed the infectivity of supernatants derived from NK clone 3.3 cells infected with IIIB. Filtered cell-free supernatant, containing approximately 0.8 to 1.5 ng of p24 antigen, was added to uninfected indicator cells. In parallel, the same cells were incubated with supernatant generated from HUT78 cells chronically infected with IIIB. Supernatants from IIIB-infected NK clone 3.3 cells induced multinucleated giant cell formation and p24 antigen production in PHA-IL-2-stimulated PBMC (Table 4) . Giant cells were evident by day 7 after infection. In contrast, HUT78 and MT-4 cells exposed to supernatants died without forming giant cells. Supematants derived from IIIB-infected NK clone 3.3 cells were also able to infect U937 cells as evidenced by p24 antigen production. This infection was followed by giant cell formation and cell death (Fig. 7) . Infection of U937 cells with IIIB generated from chronically infected HUT78 cells did not induce any morphological changes or cell death but resulted in higher p24 antigen levels (data not shown).
Effects of HIV infection on NK cell activity. To determine whether HIV infection had an effect on NK cell activity, we infected polyclonal and clonal NK cells with strain IIIB, SF2, or WMJ1. Cytotoxicity assays were done 8 to 10 days after infection, using three different target cells: K562, CMV-FS4, and IIIB-HUT78. For all these target cells, levels of cytotoxic activity with HIV-infected NK cells were similar to those obtained with uninfected NK cells (Table 5) . DISCUSSION A wide spectrum of human cells, all bearing the CD4 surface protein, support the replication of HIV (43) . The host range of HIV has been found to be broader than originally described, and there is mounting evidence that HIV can replicate in a number of CD4-cells: glial cells, neuronal cells, colorectal cells, muscle cells, endothelial cells, fibroblasts, and rhabdomyosarcoma cells (7) . Apparently, HIV-1 infection of these cells occurs via a CD4- b Target cells were prepared as described in Materials and Methods. E:T ratios were 6:1 for K562 and 25:1 for CMV-FS4 and IIIB-HUT78. c ND, Not determined. independent mechanism. Recent studies have also suggested the existence of a CD4-independent mechanism of viral entry in CD4-positive cells (11, 24, 51) .
Ruscetti et al. (45) reported that enriched large granular lymphocytes that were stimulated with IL-2 in vitro could be infected with HIV. However, large granular lymphocyte morphology is not a unique characteristic of NK cells, and the large granular lymphocyte preparations used by Ruscetti et al., although enriched for NK cells, also contained -20% T lymphocytes. Robinson et al. (44) reported coexpression of CD16 and HIV antigens in HIV-infected, IL-2-stimulated PBMC. They concluded that NK cells could be infected with HIV in vitro. In both these studies, the cell populations infected with HIV were phenotypically heterogeneous. Since in healthy donors approximately 5 to 10% CD3+ T cells coexpress CD16 (25) , identification of NK cells on the basis of the detection of CD16 alone must be interpreted with caution.
The availability of methods for growing peripheral blood NK cells in short-term culture and the availability of NK cell clones provided us with an opportunity to study the interaction of NK cells with HIV using homogeneous cell preparations. Our results indicate that purified populations of NK cells are susceptible to HIV infection. It is unlikely that contaminating CD4+ cells in polyclonal NK cell preparations were responsible for HIV replication, since CD4 mRNA was not detected in polyclonal NK cell preparations, and CD4+ cells could not be detected by flow cytometry even after such preparations were cultured in IL-2-containing media for 10 days. The inability to detect p24 antigen in the final wash after infection excluded the possibility that residual input virus was responsible for subsequent detection of p24 antigen. In addition, when NK cells were inoculated with heat-inactivated HIV, levels of p24 antigen in culture supernatant and cells were negligible (data not shown). We could also detect productive infection of NK (4) or to polarize tubulin (47) .
Opportunistic viral infections, which contribute to progression of disease in AIDS patients, may also contribute to the decreased NK cell-mediated cytotoxicity in HIV-infected patients. Severe CMV infection, in particular, has been associated with decreased NK cell activity in recipients of bone marrow transplants (40) . It (28) , might increase the number of cells in which HIV can replicate and thus be harmful.
